Funded Health Care Startups in Belgium
Belgium health care funding in the 11 most recent rounds shows one clear size outlier: PanTera’s $110M (Series A, 2024-09-11).
Belgium health care funding in the 11 most recent rounds shows one clear size outlier: PanTera’s $110M (Series A, 2024-09-11). The next-largest disclosed amounts are miDiagnostics at $32M (Series D, 2024-12-04) and Indigo Diabetes at $38M (date 2020-07-27, amount disclosed as $38M), while most other disclosed rounds sit below $20M (e.g., MYOCENE $3M on 2024-06-18; Maurice & Nora $1M on 2026-05-06), making PanTera’s round dwarf the rest.
The timing clusters into two visible windows: five rounds land between 2024-06-18 and 2025-02-28 (MYOCENE, PanTera, miDiagnostics, Salvus Health, and ReVision Implant in 2026), with the most recent entry dated 2026-05-26 (ReVision Implant, $5M). Geographically, the list is concentrated in Antwerp across multiple entries (Maurice & Nora in Antwerp on 2026-05-06; Salvus Health on 2025-02-28; PanTera on 2024-09-11 in Mol; Koios Care on 2023-01-18 in Antwerpen), and the stage mix includes 2 entries marked “Series Unknown” and 1 “undisclosed” amount (Neuroventis, 2022-07-12).
Most recent rounds
11 shownRelated listings
Frequently asked
What stands out as the largest disclosed round, and how does it compare to the rest of the list?
PanTera’s $110M (Series A, 2024-09-11) is the only disclosed round above $50M in these 11 rows; the next-highest disclosed amounts are Indigo Diabetes at $38M (2020-07-27) and miDiagnostics at $32M (Series D, 2024-12-04).
Are the most recent financings clustered in a narrow time window?
Yes. Five rounds fall between 2024-06-18 (MYOCENE $3M) and 2025-02-28 (Salvus Health $520K), spanning late 2024 into early 2025. The newest entry is ReVision Implant on 2026-05-26 for $5M, while the oldest disclosed row is Indigo Diabetes on 2020-07-27 for $38M.
Which city patterns appear most consistently, based on the locations shown?
Antwerp (and Antwerp-area cities listed as Antwerp/Antwerpen, plus nearby locations in the Antwerp province like Mol) is repeated across multiple entries: Maurice & Nora (Antwerp, 2026-05-06, $1M), Salvus Health (Antwerp, 2025-02-28, $520K), PanTera (Mol, 2024-09-11, $110M), and Koios Care (Antwerpen, 2023-01-18, $380K).
How much of the dataset is missing structured stage/amount information?
Stage or amount fields are incomplete for 3 entries: ReVision Implant is labeled “Series Unknown” (2026-05-26, $5M), Watcherr is “Series Unknown” (2023-07-05, $2M), and Neuroventis has an “undisclosed” amount (2022-07-12).
Do you see a stage mix skew, or are larger rounds spread across multiple stages?
Disclosed large rounds are not confined to one stage category: PanTera’s $110M is a Series A (2024-09-11), miDiagnostics’s $32M is Series D (2024-12-04), and Rejuvenate Biomed’s $18M is Series B (2021-10-12). Meanwhile, earlier-stage entries on smaller disclosed amounts include MYOCENE’s $3M Seed (2024-06-18) and Maurice & Nora’s $1M Pre-Seed (2026-05-06).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.